Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Kitcheetahon Oct 03, 2016 2:09pm
118 Views
Post# 25303130

RE:RE:HC approval process

RE:RE:HC approval processthere was a PDF that had a flow chart but i cant seem to locate this on the HC website, i may have been a bit off in my 84 day estimate. I did find this on HC website though.

 we are within 6 months from Dec application and there wasnt a rejection, so we should be in review 2? 30+15=45 + 3 week (21 days) = 76 days July 29th + 76 days = oct 13 ish ... so mid Oct?

Attachment 1

Interim target performance standards for management of applications for medical device licenses and investigational testing authorizations
  Performance standards (in calendar days)
Application type Screening 1 Review 1 Screening 2 Review 2
Investigational testing 30 30
Class ii licence 15 15
Class III licence 15 60 15 30
Class IV licence 15 75 15 30
Priority review
Class III & IV Licence
45 15
Licence amendment:

i) Significant Change
(Class III and IV)

15 60 15 30
ii) Significant Change (Class IV) 15 75 15 30
iii) Administrative
Change - Faxback Forms
(all classes)
15 15

TARGET = 90% of the submissions in a category to be processed withing the time shown.

(Screening 2 and Review 2: the screening and review of additional information requested during the review of an application or amendment).

Bullboard Posts